Insulet (PODD) Liabilities and Shareholders Equity (2016 - 2026)
Insulet filings provide 16 years of Liabilities and Shareholders Equity readings, the most recent being $3.2 billion for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 3.33% to $3.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $13.2 billion, a 13.66% increase, with the full-year FY2025 number at $3.2 billion, up 3.33% from a year prior.
- Liabilities and Shareholders Equity hit $3.2 billion in Q4 2025 for Insulet, up from $3.0 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.5 billion in Q1 2025 to a low of $1.8 billion in Q1 2021.
- Median Liabilities and Shareholders Equity over the past 5 years was $2.4 billion (2023), compared with a mean of $2.5 billion.
- Biggest five-year swings in Liabilities and Shareholders Equity: surged 66.04% in 2021 and later grew 0.13% in 2025.
- Insulet's Liabilities and Shareholders Equity stood at $2.0 billion in 2021, then grew by 9.87% to $2.3 billion in 2022, then increased by 14.97% to $2.6 billion in 2023, then rose by 19.3% to $3.1 billion in 2024, then grew by 3.33% to $3.2 billion in 2025.
- The last three reported values for Liabilities and Shareholders Equity were $3.2 billion (Q4 2025), $3.0 billion (Q3 2025), and $3.5 billion (Q2 2025) per Business Quant data.